Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures.
The Use of Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures: a Prospective Study
1 other identifier
interventional
200
1 country
1
Brief Summary
Conscious sedation provides adequate control of pain and anxiety for the majority of routine endoscopic procedures as well as adequate amnesia. Sedation practices vary widely, with some colonoscopists advocating sedation only for the most difficult cases of colonoscopy, while others prefer using deep sedation or general anaesthesia for colonoscopy. However, many physicians are still using moderate sedation for the majority of patients. The use of propofol, a short acting anesthetic agent, for conscious sedation provides a considerably more rapid onset of action and shorter recovery time, for which it is believed to be a safe drug of choice for patients undergoing endoscopic procedures. Although propofol cannot be used as a single agent for moderate sedation, it can be effectively titrated to moderate sedation after administration of small doses of narcotics and sedatives. The aim of this study is to compare between general anesthesia and deep sedation using propofol-fentanyl-ketamine (PFK) preparation in terms of perioperative vital signs, intraoperative awareness, post-operative pain scores, and the use of analgesia postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2020
CompletedFirst Posted
Study publicly available on registry
July 16, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedJuly 16, 2020
July 1, 2020
4 months
July 13, 2020
July 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Transient decrease in oxygen saturation
the investigators will record any episodes of transient reduction of oxygen saturation.
1 hour
Blood pressure stability
the investigators will record changes in blood pressure after induction of anesthesia
1 hour
Recovery time
the investigators will document recovery time in the post anesthesia care unit (PACU) until recovery of full consciousness.
2 hours
Study Arms (2)
PF group
EXPERIMENTALThe first group will undergo general anesthesia using Fentanyl and Propofol.
PFK group
EXPERIMENTALThe second group will receive a mixture that consists of Fentanyl, Propofol, and Ketamine. In addition, Lidocaine will be added to reduce the pain on injection caused by Propofol.
Interventions
Patients will be anesthetized using Fentanyl (2 mcg/kg) and Propofol (1-2 mg/kg).
Each patient received an initial dose of 0.05 ml/kg from the solution, then after waiting for 60 seconds, another 0.05 ml/kg were given. Maintenance was given as boluses of 0.025 ml/kg every three to five minutes.
Eligibility Criteria
You may qualify if:
- patients who were admitted for endoscopic and colonoscopic procedures.
- ASA (American Society of Anaesthesiologists physical status) score from 1 to 3.
You may not qualify if:
- patient refusal.
- urgent and emergency cases, which were not elective procedures.
- Surgeries that were expected to take a long duration (more than 1.5 hour).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jordan University Hospital
Amman, 13046, Jordan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 13, 2020
First Posted
July 16, 2020
Study Start
August 1, 2020
Primary Completion
December 1, 2020
Study Completion
June 1, 2021
Last Updated
July 16, 2020
Record last verified: 2020-07